|
From the Department of Medicine, St. Michael's Hospital (Ray), the Institute for Clinical Evaluative Sciences, Sunnybrook and Women's College Health Sciences Centre (Vermeulen), the Departments of Laboratory Medicine and Pathobiology, Medicine and Paediatrics (Genetics), University of Toronto (Cole), the Ontario Maternal Serum Screening Database Department, Genetics Programme (Meier) and the Department of Genetics (Wyatt), North York General Hospital, Toronto, Ont.
Background: Maternal body mass and the presence of diabetes mellitus are probable risk factors for neural tube defects (NTDs). The association between maternal ethnicity and the risk of NTDs remains poorly understood, however.
Methods: We performed a retrospective population-based study and included all women in Ontario who underwent antenatal maternal screening (MSS) at 15 to 20 weeks' gestation between 1994 and late 2000. Self-declared maternal date of birth, ethnicity and weight and the presence of pregestational diabetes mellitus were recorded in a standardized fashion on the MSS requisition sheet. NTDs were detected antenatally by ultrasonography or fetal autopsy and postnatally by considering all live and stillborn affected infants beyond 20 weeks' gestation. The risk of open NTD was evaluated across the 5 broad ethnic groups used for MSS, with white ethnicity as the referent.
Results: Compared with white women (n = 290 799), women of First Nations origin (n = 1551) were at increased associated risk of an NTD-affected pregnancy (adjusted odds ratio [OR] 5.2, 95% confidence interval [CI] 2.112.9). Women of other ethnic origins were not at increased associated risk compared with white women (women of Asian origin [n = 75 590]: adjusted OR 0.9, 95% CI 0.61.3; black women [n = 25 966]: adjusted OR 0.6, 95% CI 0.31.1; women of "other" ethnic origin [n = 10 009]: adjusted OR 0.1, 95% CI 0.020.9).
Interpretation: The associated risk of NTD-affected pregnancies was higher among women of First Nations origin than among women of other ethnic origins. The mechanisms for this discrepancy should be explored.
This article has been cited by other articles:
![]() |
M. D Thompson, D. E. Cole, and J. G Ray Vitamin B-12 and neural tube defects: the Canadian experience Am. J. Clinical Nutrition, February 1, 2009; 89(2): 697S - 701S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ryan-Harshman and W. Aldoori Folic acid and prevention of neural tube defects Can Fam Physician, January 1, 2008; 54(1): 36 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Williams, S. A. Rasmussen, A. Flores, R. S. Kirby, and L. D. Edmonds Decline in the Prevalence of Spina Bifida and Anencephaly by Race/Ethnicity: 1995-2002 Pediatrics, September 1, 2005; 116(3): 580 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-L. Wang, H. Quan, and D. Schopflocher Neural tube defects Can. Med. Assoc. J., January 18, 2005; 172(2): 158 - 158. [Full Text] [PDF] |
||||
![]() |
R. B. Lowry Neural tube defects Can. Med. Assoc. J., January 18, 2005; 172(2): 159 - 160. [Full Text] [PDF] |
||||
![]() |
J. G. Ray Neural tube defects Can. Med. Assoc. J., January 18, 2005; 172(2): 160 - 160. [Full Text] [PDF] |
||||
![]() |
J.A. C. Delaney Neural tube defects Can. Med. Assoc. J., January 18, 2005; 172(2): 157 - 158. [Full Text] [PDF] |
||||
![]() |
V. Dubey Neural tube defects Can. Med. Assoc. J., January 18, 2005; 172(2): 158 - 158. [Full Text] [PDF] |
||||
![]() |
H. Dean, K. Watson, and E. A.C. Sellers Neural tube defects Can. Med. Assoc. J., January 18, 2005; 172(2): 158 - 159. [Full Text] [PDF] |
||||
Read all eLetters